Literature DB >> 9454713

Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.

G Duncan1, I Pelletier, F Colbère-Garapin.   

Abstract

After 2.5 months of persistent infection in human neuroblastoma cells by the type 3 poliovirus (PV3) wild-type Leon strain, a mutant (PVpi), L2-2, capable of establishing a persistent infection in nonneural HEp-2c cells was isolated. Sequence analysis of the viral capsid protein genes revealed the presence of seven missense mutations, three of which were also present in a second PVpi, suggesting that they could be important determinants of the persistent phenotype. When the three mutations were introduced into the lytic Leon strain separately, in pairs or all together, all but one of the viruses was capable of establishing a persistent infection. However, aside from the triple mutant, only one mutant virus, bearing a Leu at position VP213 in the capsid interior and an Asn at position VP1290 on the capsid surface, was capable of establishing persistent infections in more than 30% of the cultures. When present together, these two determinants affect the early steps of the virus cycle including cell binding and the receptor-mediated conformational changes believed to be necessary for viral penetration and uncoating. In fact, this persistent double mutant appears to undergo a novel capsid transition when in contact with the human PV receptor, altering from the native virion which sediments at 160S to a form which sediments at about 147S. We propose that this modification could be the mechanism by which PV3 is able to establish persistent infections in HEp-2c cell cultures. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454713     DOI: 10.1006/viro.1997.8955

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Enhanced gene silencing in cells cured of persistent virus infection by RNA interference.

Authors:  Isabelle Pelletier; Aure Saulnier; Cynthia Brisac; Sophie Jegouic; Nicolas Vabret; Frédéric Tangy; Bruno Blondel; Florence Colbère-Garapin
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.

Authors:  Karine Labadie; Aure Saulnier; Sandra Martin-Latil; Florence Colbère-Garapin
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.

Authors:  E K Alidjinou; I Engelmann; J Bossu; C Villenet; M Figeac; M-B Romond; F Sané; D Hober
Journal:  Virulence       Date:  2017-01-23       Impact factor: 5.882

5.  Persistent infection promotes cross-species transmissibility of mouse hepatitis virus.

Authors:  R S Baric; E Sullivan; L Hensley; B Yount; W Chen
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 6.  Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death.

Authors:  Katharine G Harris; Carolyn B Coyne
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-15       Impact factor: 7.638

7.  Persistent equine arteritis virus infection in HeLa cells.

Authors:  Jianqiang Zhang; Peter J Timoney; N James MacLachlan; William H McCollum; Udeni B R Balasuriya
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  Non-diarrhoeal increased frequency of bowel movements (IFoBM-ND): enterovirus association with the symptoms in children.

Authors:  C Durga Rao; P P Maiya; M Ananda Babu
Journal:  BMJ Open Gastroenterol       Date:  2015-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.